SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-034287
Filing Date
2021-06-24
Accepted
2021-06-24 16:27:46
Documents
12
Period of Report
2021-06-24
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K ubx-8k_20210624.htm   iXBRL 8-K 57830
  Complete submission text file 0001564590-21-034287.txt   188550

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ubx-20210624.xsd EX-101.SCH 5797
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ubx-20210624_lab.xml EX-101.LAB 19466
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ubx-20210624_pre.xml EX-101.PRE 11643
5 EXTRACTED XBRL INSTANCE DOCUMENT ubx-8k_20210624_htm.xml XML 3561
Mailing Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005 (415) 328-5504
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38470 | Film No.: 211043156
SIC: 2834 Pharmaceutical Preparations